Type: other status: Curated disease: Cancer species: Homo sapiens citation: A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S.Cancer Res. 2005 May 15;65(10):4059-66. A gene-expression signature as a predictor of survival in breast cancer. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R.N Engl J Med. 2002 Dec 19;347(25):1999-2009. Gene expression profiling predicts clinical outcome of breast cancer. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH.Nature. 2002 Jan 31;415(6871):530-6. pubmedId: 15899795 SampleType: Tumor Tissue numSamples: 295 tissueType: Breast Institution: Merck & Co. releaseDate: 1265846400000 Investigator: Friend Internal_Name: Breast_Cancer_NKI release_notes: NKI Dataset This is the expression and clinical data from the original Rosetta papers on breast cancer (PMID: 11823860, PMID: 12490681, PMID: 15899795, see publications folder). The data is publicly available from the old Rosetta website, and approval to release through Sage has been granted by Merck. Expression data was generated on an in-house Hu25k microarray using the technology that was the precursor to Agilents flexjet arrays. locationStatus: available syn3275760 syn88645 syn4657